The 2025 South Central AUA annual meeting included a session on bladder cancer, featuring a presentation from Dr. Yair Lotan ...

The immune checkpoint inhibitor combination regimen has become the initial standard of care for metastatic RCC, given its ...

Detalimogene voraplasmid is a novel, investigational, non-integrating, non-viral genetic medicine-based immunotherapy carrying a plasmid that simultaneously expresses IL-12 and regulators of RIG-I.

The 2025 South Central AUA annual meeting included a session on kidney cancer, featuring a presentation from Dr. Vedant Agrawal discussing patient-reported barriers, social determinants, and racial ...

The baseline characteristics of the two cohorts are as follows: ...

Dr. Palacios concluded his presentation discussing the role of an intraoperative steep Trendelenburg break during robot-assisted laparoscopic radical prostatectomies with the following take-home ...

This was a descriptive, observational, and retrospective study of patients who underwent radical prostatectomy and PSMA PET/CT for staging between October 2019 and May 2024. The objective of the study ...

(UroToday.com) The 2025 South Central AUA annual meeting included a session on bladder cancer, featuring a presentation from Dr. Janet Kukreja discussing a pilot study of a web-based urinary diversion ...

The 2025 South Central AUA annual meeting included a session on bladder cancer, featuring a trials in progress presentation from Dr. Yair Lotan discussing a streamlined, patient-centric design of the ...

The 2025 South Central AUA annual meeting included a session on urothelial cancer, featuring a presentation from Dr. Patrick Burnam discussing long-term outcomes of adjuvant UGN-101 in a real-world ...

Zachary Klaassen hosts Luis Salgado to discuss metastasis-directed therapy for low-volume hormone-sensitive prostate cancer. The conversation highlights the challenge of interpreting disease volume in ...

David Morris and Brian Chapin discuss practical management of metastatic hormone-sensitive prostate cancer. The conversation addresses key clinical dilemmas facing urologists and medical oncologists, ...